08:15 - 09:30 | 62 | Lung physiology throughout life: applicability and assessment | Oral Presentation |
08:15 - 09:30 | 63 | Best abstracts in pulmonary rehabilitation and chronic care | Oral Presentation |
08:15 - 09:30 | 64 | Early childhood risk factors for wheezing and later asthma | Oral Presentation |
08:30 - 09:30 | 66 | Clinical problems in respiratory medicine: 1 | Thematic Poster |
08:30 - 09:30 | 67 | Chronic cough, airway diseases and methods | Thematic Poster |
08:30 - 09:30 | 68 | Exacerbations in COPD: biomarkers and management | Thematic Poster |
08:30 - 09:30 | 69 | Interest of PROMS in chronic airway diseases | Thematic Poster |
08:30 - 09:30 | 70 | Miscellaneous: biomarkers for the management of chronic lung diseases | Thematic Poster |
08:30 - 09:30 | 71 | Occupational asthma and upper airway diseases | Thematic Poster |
08:30 - 09:30 | 72 | Paediatric sleep disorders and management in various diseases | Thematic Poster |
08:30 - 09:30 | 73 | Cystic fibrosis in children and adolescents | Thematic Poster |
08:30 - 09:30 | 74 | Thoracic surgery: different perspectives of the field | Thematic Poster |
08:30 - 09:30 | 75 | Extrapulmonary traits and respiratory physiotherapy | Thematic Poster |
08:30 - 09:30 | 76 | Biomarkers in COVID | Thematic Poster |
08:30 - 09:30 | 77 | Pulmonary rehabilitation in clinical conditions beyond COVID | Thematic Poster |
08:30 - 09:30 | 78 | Bronchiectasis: 1 | Thematic Poster |
08:30 - 09:30 | 79 | COVID complications | Thematic Poster |
08:30 - 09:30 | 80 | Tuberculosis, COVID-19 and other coinfections | Thematic Poster |
08:30 - 09:30 | 81 | Pleural and thymic malignancies: from bench to bedside | Thematic Poster |
08:30 - 09:30 | 82 | Interstitial lung diseases diagnosis in the COVID-19 era: new tools for new challenges | Thematic Poster |
08:30 - 09:30 | 83 | Risk assessment in pulmonary arterial hypertension | Thematic Poster |
08:30 - 09:30 | 84 | The many faces of interventional bronchoscopy | Thematic Poster |
08:30 - 09:30 | 85 | Asthma and COVID-19 management in primary care | Thematic Poster |
08:30 - 09:30 | 86 | The lung after COVID: functional recovery after SARS-CoV-2 infection | Thematic Poster |
08:30 - 09:30 | 87 | Severe COVID-19: clinical data | Thematic Poster |
08:30 - 09:30 | 88 | High flow therapy and NIV in the acute and chronic setting | Thematic Poster |
08:30 - 09:30 | 89 | Impact of the external and internal exposome on chronic lung disease | Thematic Poster |
08:30 - 09:30 | 90 | Translational modelling of lung diseases | Thematic Poster |
08:30 - 09:30 | 91 | Sleep and breathing in different respiratory and nonrespiratory disorders | Thematic Poster |
08:45 - 09:00 | 92 | Welcome and introduction | News from the Studio |
09:15 - 09:45 | 93 | T2 high and T2 low asthma: should we care, or should we only care about asthma? | Pro-Con debate |
09:30 - 11:00 | 94 | Airway diseases | State of the art session |
09:30 - 11:00 | 95 | Holistic management and rehabilitation of fibrosing interstitial lung diseases | Symposium |
09:30 - 11:00 | 96 | Lungs on fire: Lung cancer? | Clinical cases |
09:30 - 11:00 | 97 | Beyond COVID: translating COVID treatment successes to all-cause ARDS | Hot topics |
09:30 - 11:00 | 98 | Moving to prevention of preschool wheeze and asthma: almost there? | Hot topics |
09:45 - 11:00 | 99 | Novel targets and approaches in pulmonary translational research | Oral Presentation |
09:45 - 11:00 | 100 | Best abstracts on tobacco, nicotine and cannabis | Oral Presentation |
09:45 - 11:00 | 101 | Lung allograft dysfunction: towards better monitoring and treatment | Oral Presentation |
09:45 - 11:00 | 102 | Update on nontuberculous mycobacterial pulmonary diseases | Mini symposium |
10:00 - 10:30 | 103 | Idiopathic pulmonary fibrosis: an update of diagnosis and treatment recommendations | Guidelines session |
10:45 - 11:15 | 107 | Transbronchial (cryo)biopsy and surgical lung biopsy in interstitial lung diseases | Guidelines session |
11:15 - 12:45 | 113 | ALERT 1: COPD and hospital management | Clinical trials session |
11:15 - 12:45 | 114 | The best of the European Respiratory Journal in 2022 | Journal session |
11:15 - 12:45 | 115 | Thoracic oncology | State of the art session |
11:15 - 12:45 | 116 | Using data to make the case for change: the launch of the Lung Facts resource | Hot topics |
11:15 - 12:45 | 117 | Lung function testing from preschool age to adolescence: are we done with spirometry? | Symposium |
11:15 - 12:30 | 118 | Learning is a treasure that follows its owner everywhere | Mini symposium |
11:15 - 12:30 | 119 | COPD treatment: new mechanisms and novel insights | Oral Presentation |
11:15 - 12:30 | 120 | Advances in epidemiology, diagnosis and treatment of tuberculosis | Oral Presentation |
11:15 - 12:30 | 121 | Innovations in interventional pulmonology: pushing boundaries with beams, tunnels and robots | Oral Presentation |
11:30 - 12:30 | 122 | Patient ventilator asynchrony (PVA) from ICU to home | Online skills lab |
12:45 - 14:00 | 128 | Malignant pleural effusion and mesothelioma: diagnosis and optimal management | Oral Presentation |
12:45 - 14:00 | 129 | Expanding the insight into COVID-19 dyspnoea | Oral Presentation |
12:45 - 14:00 | 130 | New trends in exercise, physical activity and behavioural changes in COPD, ILD and asthma | Oral Presentation |
13:00 - 14:30 | 131 | Paediatric lung function and sleep measurements | Online skills lab |
13:00 - 14:00 | 139 | Biomarkers in COVID-19 | Thematic Poster |
13:00 - 14:00 | 140 | Severe asthma: from phenotypes to exacerbations | Thematic Poster |
13:00 - 14:00 | 141 | Chronic cough: management and impact on quality of life | Thematic Poster |
13:00 - 14:00 | 142 | New insights into asthma immunology: from mouse to man | Thematic Poster |
13:00 - 14:00 | 143 | Diagnosis, risk factors and management of asthma | Thematic Poster |
13:00 - 14:00 | 144 | Tobacco and nicotine: where are we after the pandemic | Thematic Poster |
13:00 - 14:00 | 145 | Finding the way to a correct asthma diagnosis | Thematic Poster |
13:00 - 14:00 | 146 | Predictors of lung function and respiratory morbidity in children | Thematic Poster |
13:00 - 14:00 | 147 | Risk stratification in lung transplant patients | Thematic Poster |
13:00 - 14:00 | 148 | Updates on physical activity, exercise and nonconventional therapies | Thematic Poster |
13:00 - 14:00 | 149 | COVID imaging and diagnosis | Thematic Poster |
13:00 - 14:00 | 150 | Clinical problems in pleural and respiratory muscle disorders | Thematic Poster |
13:00 - 14:00 | 151 | Pleural and other respiratory infections | Thematic Poster |
13:00 - 14:00 | 152 | Vaccination | Thematic Poster |
13:00 - 14:00 | 153 | Diagnostics and biomarkers in lung cancer | Thematic Poster |
13:00 - 14:00 | 154 | Comorbidities and symptoms in interstitial lung diseases think out of the box | Thematic Poster |
13:00 - 14:00 | 155 | Advances in rare interstitial lung diseases | Thematic Poster |
13:00 - 14:00 | 156 | Suspicion and management of pulmonary embolism | Thematic Poster |
13:00 - 14:00 | 157 | Thoracic ultrasound: from central airways to the chest wall | Thematic Poster |
13:00 - 14:00 | 158 | Physiology and pulmonary rehabilitation | Thematic Poster |
13:00 - 14:00 | 159 | New techniques and improvements in lung function assessment | Thematic Poster |
13:00 - 14:00 | 160 | Non-COVID-19: mechanical ventilation and beyond | Thematic Poster |
13:00 - 14:00 | 161 | New insights and biomarkers in COPD | Thematic Poster |
13:00 - 14:00 | 162 | Contribution of host-microbe interactions to respiratory disease | Thematic Poster |
13:00 - 14:00 | 163 | Diagnostic modalities for sleep disordered breathing | Thematic Poster |
13:00 - 14:00 | 164 | Asthma treatment: real-world studies and other diseases | Thematic Poster |
14:15 - 15:45 | 167 | Respiratory infections | State of the art session |
14:15 - 15:45 | 168 | From the Editor's Desk | Journal session |
14:15 - 15:45 | 169 | Lungs on fire: Pulmonary vascular diseases? | Clinical cases |
14:15 - 15:45 | 170 | What I learnt from COVID-19 to better manage my current patients | Symposium |
14:15 - 15:45 | 171 | Cell death modalities regulating the onset and progression of chronic lung diseases | Symposium |
14:15 - 15:30 | 172 | Biomarkers and beyond in lung cancer | Oral Presentation |
14:15 - 15:30 | 173 | What is hot in interstitial lung diseases | Oral Presentation |
14:15 - 15:30 | 174 | Best of imaging research: highlights in 2022 | Oral Presentation |
14:15 - 15:30 | 175 | Chronic airway diseases: from phenotypes to severity | Oral Presentation |
14:45 - 16:15 | 177 | Spanish/Portuguese programme 2022 | Language session |
15:45 - 17:00 | 183 | COVID-19 acute respiratory distress syndrome | Oral Presentation |
15:45 - 17:00 | 184 | New respiratory physiological tests and home assessment of sleep disturbed breathing in children | Oral Presentation |
15:45 - 17:00 | 185 | Hot topics in connective tissue disease-associated interstitial lung disease | Oral Presentation |
15:45 - 17:00 | 186 | Tobacco control during the pandemic | Mini symposium |
16:00 - 17:30 | 187 | Lungs on fire: Respiratory infections? | Clinical cases |
16:00 - 17:30 | 188 | The future of inhalation therapy in COPD | Hot topics |
16:00 - 17:30 | 189 | Update on pulmonary embolism management | Symposium |
16:00 - 17:30 | 190 | Post-critical care long COVID: reducing the physical and emotional toll | Symposium |
16:00 - 17:30 | 191 | Reflections from the 2022 Lung Science Conference | Symposium |
16:30 - 17:30 | 192 | Hypoxic challenge and oxygen assessments | Online skills lab |